Moderna Inc (NASDAQ: MRNA) shares are trading higher by 4.7% at $165.44 Thursday afternoon after a Japan health panel recommended approval of the company's COVID-19 vaccine.
Last week featured eight announced SPAC deals. The week also had earnings from several well-known former SPACs.
Here is a look back at the week that was SPACs for deals and headline news, all covered on Benzinga’s “SPACs Attack.”